Page last updated: 2024-10-29

iotrolan and Dyskinesia, Drug-Induced

iotrolan has been researched along with Dyskinesia, Drug-Induced in 1 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bååth, L1
Besjakov, J1
Pettersson, G1

Other Studies

1 other study available for iotrolan and Dyskinesia, Drug-Induced

ArticleYear
Effects of nonionic monomeric and dimeric contrast media on the twitching reaction of the rat. Importance of osmolality and electrolyte content.
    Investigative radiology, 1994, Volume: 29, Issue:11

    Topics: Animals; Calcium Chloride; Contrast Media; Dyskinesia, Drug-Induced; Female; Head; Iohexol; Male; Ma

1994